Dr. Raju is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3010 Childrens Way
San Diego, CA 92123Phone+1 858-966-5811
Summary
- Dr. Praveen Raju is a Pediatric Neurologist with a focus in Pediatric Neuro-Oncology in San Diego, CA and is affiliated with Rady Children's Hospital. He received his medical degree from the Perelman School of Medicine at the University of Pennsylvania and has been in practice 17 years. He is experienced in neurofibromatosis, tuberous sclerosis, medulloblastoma, pediatric brain tumors, and neurogenetics. He has more than 30 publications.
Education & Training
- Boston Children’s Hospital/Beth Israel Deaconess Medical Center/Harvard Medical SchoolFellowship, Child Neurology, 2003 - 2006
- New York Presbyterian Hospital (Cornell Campus)Residency, Pediatrics, 2001 - 2003
- University of Pennsylvania School of MedicinePh.D., 1992 - 2001
- Perelman School of Medicine at the University of PennsylvaniaClass of 2001
- University of PennsylvaniaB.A., 1989 - 1992
Certifications & Licensure
- FL State Medical License 2020 - Present
- CA State Medical License 2024 - 2026
- NY State Medical License 2006 - 2025
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Awards, Honors, & Recognition
- K08 Clinical Scientist Development Award NIH/NINDS, 2009
- Pediatric Scientist Development Program (PSDP) Fellow NIH/NICHD, 2006-2009
- Society for Penn Medical Scholars University of Pennsylvania School of Medicine, 1992-2001
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsChildhood cancer mutagenesis caused by transposase-derived PGBD5.Makiko Yamada, Ross R Keller, Rodrigo Lopez Gutierrez, Daniel Cameron, Hiromichi Suzuki
Science Advances. 2024-03-22 - 3 citationsA road map for the treatment of pediatric diffuse midline glioma.Carl Koschmann, Wajd N Al-Holou, Marta M Alonso, Jamie Anastas, Pratiti Bandopadhayay
Cancer Cell. 2024-01-08 - 52 citationsP-selectin-targeted nanocarriers induce active crossing of the blood-brain barrier via caveolin-1-dependent transcytosis.Daniel E Tylawsky, Hiroto Kiguchi, Jake Vaynshteyn, Jeffrey Gerwin, Janki Shah
Nature Materials. 2023-03-01
Books/Book Chapters
Abstracts/Posters
- Early Detection and Tumor Characterization of a Novel Sporadic Model of Shh-driven Medulloblastoma using Contrast Enhanced MRI.Suero-Abreu G, Raju GP, Aristizabal O, Pham D, Houston EJ, Volkova E, Joyner Al, Turnbull DH, American Association for Cancer Research (AACR) Meeting, Washington, DC, 1/1/2013
- Preclinical Assessment of Arsenic Trioxide and Resistance Mechanisms Using a Novel Mouse Model of Sporadic Medulloblastoma.Maganty, Mi J, and Raju GP, American Brain Tumor Association Meeting, Chicago, IL, 1/1/2013
- Preclinical Assessment of GANT61 and Resistance Mechanisms Using a Novel Mouse Model of Sporadic Medulloblastoma.Wu YL, Mi J, and Raju GP, Child Neurology Society Meeting, Austin, TX, 1/1/2013
- Join now to see all
Lectures
- "Novel preclinical approaches to understanding brain tumor formation, intratumoral heterogeneity, and treatment resistance"1/1/2014
- "Novel translational approaches for improving outcomes of brain tumor patients"1/1/2013
- "Novel Translational Approaches for Pediatric Brain Tumors"1/1/2013
- Join now to see all
Press Mentions
- Nanoparticles Target Medulloblastoma Tumor to Improve Drug Therapy and Reduce ToxicityMarch 3rd, 2023
- New Anti-Cancer Drug Delivery Technology for Brain Tumors Is More Effective, Less Toxic [STUDY]March 3rd, 2023
- Scientists Develop Novel Approach to Enhance Drug Delivery for Brain Tumors in ChildrenFebruary 27th, 2023
- Join now to see all
Professional Memberships
- Child Neurology SocietyMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: